175 related articles for article (PubMed ID: 14273669)
21. Construction and characterization of virG (icsA)-deleted Escherichia coli K12-Shigella flexneri hybrid vaccine strains.
Alexander WA; Hartman AB; Oaks EV; Venkatesan MM
Vaccine; 1996 Aug; 14(11):1053-61. PubMed ID: 8879102
[TBL] [Abstract][Full Text] [Related]
22. [Conjugation of E. Coli P4x and Shigella flexneri 2a. II. Production of S. flexneri Hfr strain].
Zaleska H; Janczura E; Stypulkowska-Misiurewicz
Med Dosw Mikrobiol; 1970; 22(2):119-23. PubMed ID: 4913813
[No Abstract] [Full Text] [Related]
23. Factors affecting virulence of Shigella flexneri: defective methionine synthesis in an Escherichia coli-Shigella hybrid.
Rothman SW; Corwin LM
J Bacteriol; 1972 Oct; 112(1):176-82. PubMed ID: 4562393
[TBL] [Abstract][Full Text] [Related]
24. BIOCHEMICAL REACTIONS AND VIRULENCE OF E. COLI O124: K72 (17).
SERENY B
Acta Microbiol Acad Sci Hung; 1963; 10():11-8. PubMed ID: 14043490
[No Abstract] [Full Text] [Related]
25. Alterations in the pathogenicity of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri.
Sansonetti PJ; Hale TL; Dammin GJ; Kapfer C; Collins HH; Formal SB
Infect Immun; 1983 Mar; 39(3):1392-402. PubMed ID: 6341237
[TBL] [Abstract][Full Text] [Related]
26. On the metabolic characteristic of hybrids Shigella flexneri x Escherichia coli devoid of their ability for intracellular multiplication in the epithelial cells. I. Glycolysis.
Radoutcheva T; Veljanov D; Popov C; Bondarenko VM
Zentralbl Bakteriol Orig A; 1976 Aug; 235(4):404-7. PubMed ID: 790853
[TBL] [Abstract][Full Text] [Related]
27. TRANSFER OF EPISOMIC ELEMENTS TO PROTEUS. II. NATURE OF LAC+ PROTEUS STRAINS ISOLATED FROM CLINICAL SPECIMENS.
FALKOW S; WOHLHIETER JA; CITARELLA RV; BARON LS
J Bacteriol; 1964 Dec; 88(6):1598-601. PubMed ID: 14240944
[TBL] [Abstract][Full Text] [Related]
28. [Genetic characteristics and trends in the spread of a new Shigella flexneri subserovar with the antigenic formula IV:7,8].
Bondarenko VM; Petrovskaia VG; Priamukhina NS; Bobrova TP
Zh Mikrobiol Epidemiol Immunobiol; 1987 Feb; (2):42-6. PubMed ID: 2437740
[TBL] [Abstract][Full Text] [Related]
29. Plasmid-mediated invasiveness of "Shigella-like" Escherichia coli.
Sansonetti PJ; d'Hauteville H; Formal SB; Toucas M
Ann Microbiol (Paris); 1982; 133(3):351-5. PubMed ID: 7049041
[TBL] [Abstract][Full Text] [Related]
30. Mutation in Shigella flexneri resulting in loss of ability to penetrate HeLa cells and loss of glycerol kinase activity.
Kim R; Corwin LM
Infect Immun; 1974 May; 9(5):916-23. PubMed ID: 4363235
[TBL] [Abstract][Full Text] [Related]
31. Experimental Shigella infections. VI. Role of the small intestine in an experimental infection in guinea pigs.
FORMAL SB; ABRAMS GD; SCHNEIDER H; SPRINZ H
J Bacteriol; 1963 Jan; 85(1):119-25. PubMed ID: 13958748
[TBL] [Abstract][Full Text] [Related]
32. Differences in blood group B-specific mucinase activity between virulent and avirulent Shigella flexneri 2a strains.
Prizont R; Reed WP
Microb Pathog; 1991 Aug; 11(2):129-35. PubMed ID: 1961109
[TBL] [Abstract][Full Text] [Related]
33. CHROMOSOME TRANSFER KINETICS OF SALMONELLA HFR STRAINS.
JOHNSON EM; FALKOW S; BARON LS
J Bacteriol; 1964 Aug; 88(2):395-400. PubMed ID: 14203356
[TBL] [Abstract][Full Text] [Related]
34. Virulence plasmids of enteroinvasive Escherichia coli and Shigella flexneri integrate into a specific site on the host chromosome: integration greatly reduces expression of plasmid-carried virulence genes.
Zagaglia C; Casalino M; Colonna B; Conti C; Calconi A; Nicoletti M
Infect Immun; 1991 Mar; 59(3):792-9. PubMed ID: 1997431
[TBL] [Abstract][Full Text] [Related]
35. Surface hydrophobicity of plasmid-carrying virulent Shigella flexneri and their avirulent variants.
Seltmann G; Pál T; Tschäpe H
J Basic Microbiol; 1986; 26(5):283-7. PubMed ID: 3537274
[TBL] [Abstract][Full Text] [Related]
36. vacC, a virulence-associated chromosomal locus of Shigella flexneri, is homologous to tgt, a gene encoding tRNA-guanine transglycosylase (Tgt) of Escherichia coli K-12.
Durand JM; Okada N; Tobe T; Watarai M; Fukuda I; Suzuki T; Nakata N; Komatsu K; Yoshikawa M; Sasakawa C
J Bacteriol; 1994 Aug; 176(15):4627-34. PubMed ID: 8045893
[TBL] [Abstract][Full Text] [Related]
37. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
Altboum Z; Barry EM; Losonsky G; Galen JE; Levine MM
Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735
[TBL] [Abstract][Full Text] [Related]
38. Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine.
Lindberg AA; Karnell A; Pál T; Sweiha H; Hultenby K; Stocker BA
Microb Pathog; 1990 Jun; 8(6):433-40. PubMed ID: 2266855
[TBL] [Abstract][Full Text] [Related]
39. Involvement of a plasmid in the invasive ability of Shigella flexneri.
Sansonetti PJ; Kopecko DJ; Formal SB
Infect Immun; 1982 Mar; 35(3):852-60. PubMed ID: 6279518
[TBL] [Abstract][Full Text] [Related]
40. [Various aspects of competitive relationship between Shigella and Escherichia coli].
Bondarenko VM; Iuditskaia NM; Kurbatova NA; Petrovskaia VG
Zh Mikrobiol Epidemiol Immunobiol; 1978 Apr; (4):102-7. PubMed ID: 358685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
